IL17A and inflammatory bowel disease: However, they also contribute to the evolution and aggravation of IBD if IL-22 and IL-17, along with IFN-γ, become overexpressed due to dysregulation of ILC3 functions and their transition towards ILC1 in the pathological state [161].